KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Return on Assets (2016 - 2025)

Historic Return on Assets for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q4 2025 value amounting to 0.06%.

  • Alnylam Pharmaceuticals' Return on Assets rose 1200.0% to 0.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.06%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.07% for FY2025, which is 1400.0% up from last year.
  • According to the latest figures from Q4 2025, Alnylam Pharmaceuticals' Return on Assets is 0.06%, which was up 1200.0% from 0.02% recorded in Q3 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Return on Assets peaked at 0.06% during Q4 2025, and registered a low of 0.34% during Q3 2022.
  • In the last 5 years, Alnylam Pharmaceuticals' Return on Assets had a median value of 0.19% in 2021 and averaged 0.17%.
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Return on Assets plummeted by -1000bps in 2022 and then soared by 2900bps in 2024.
  • Over the past 5 years, Alnylam Pharmaceuticals' Return on Assets (Quarter) stood at 0.24% in 2021, then crashed by -33bps to 0.32% in 2022, then skyrocketed by 64bps to 0.11% in 2023, then skyrocketed by 43bps to 0.07% in 2024, then skyrocketed by 186bps to 0.06% in 2025.
  • Its Return on Assets was 0.06% in Q4 2025, compared to 0.02% in Q3 2025 and 0.06% in Q2 2025.